BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Seifert M, Reichrath J. The role of the human DNA mismatch repair gene hMSH2 in DNA repair, cell cycle control and apoptosis: implications for pathogenesis, progression and therapy of cancer. J Mol Histol. 2006;37:301-307. [PMID: 17080293 DOI: 10.1007/s10735-006-9062-5] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Dey A, Flajšhans M, Pšenička M, Gazo I. DNA repair genes play a variety of roles in the development of fish embryos. Front Cell Dev Biol 2023;11:1119229. [PMID: 36936683 DOI: 10.3389/fcell.2023.1119229] [Reference Citation Analysis]
2 Daniels HG, Knicely BG, Miller AK, Thompson A, Plattner R, Goellner EM. Inhibition of ABL1 by tyrosine kinase inhibitors leads to a downregulation of MLH1 by Hsp70-mediated lysosomal protein degradation. Front Genet 2022;13:940073. [PMID: 36338985 DOI: 10.3389/fgene.2022.940073] [Reference Citation Analysis]
3 Luo H, Cui L, Shen K, Li R, Wang Z, Xie Z. HER2 Overexpression and Mismatch Repair Deficiency are Correlated with Malignancy in Colorectal Cancer. Cancer Manag Res 2021;13:3443-54. [PMID: 33907467 DOI: 10.2147/CMAR.S297596] [Reference Citation Analysis]
4 Hariri M, Gholami A, Mirhafez SR, Bidkhori M, Sahebkar A. A pilot study of the effect of curcumin on epigenetic changes and DNA damage among patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled, clinical trial. Complement Ther Med 2020;51:102447. [PMID: 32507446 DOI: 10.1016/j.ctim.2020.102447] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
5 Koosha S, Mohamed Z, Sinniah A, Alshawsh MA. Investigation into the Molecular Mechanisms underlying the Anti-proliferative and Anti-tumorigenesis activities of Diosmetin against HCT-116 Human Colorectal Cancer. Sci Rep 2019;9:5148. [PMID: 30914796 DOI: 10.1038/s41598-019-41685-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
6 Ni HL, Han YJ, Jin XH. Effect of hMLH1, hMSH2, hMSH6, integrin β1, and Ki-67 expression on prognosis of colorectal cancer. Shijie Huaren Xiaohua Zazhi 2018; 26(32): 1857-1863 [DOI: 10.11569/wcjd.v26.i32.1857] [Reference Citation Analysis]
7 Lee J, Shishido-Hara Y, Suzuki K, Shimizu S, Kobayashi K, Kamma H, Shiokawa Y, Nagane M. Prognostic factors for primary central nervous system lymphomas treated with high-dose methotrexate-based chemo-radiotherapy. Jpn J Clin Oncol 2017;47:925-34. [PMID: 28981733 DOI: 10.1093/jjco/hyx098] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
8 Rohlin A, Rambech E, Kvist A, Törngren T, Eiengård F, Lundstam U, Zagoras T, Gebre-Medhin S, Borg Å, Björk J, Nilbert M, Nordling M. Expanding the genotype-phenotype spectrum in hereditary colorectal cancer by gene panel testing. Fam Cancer 2017;16:195-203. [PMID: 27696107 DOI: 10.1007/s10689-016-9934-0] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 6.7] [Reference Citation Analysis]
9 Bone KM, Wang P, Wu F, Wu C, Li L, Bacani JT, Andrew SE, Lai R. NPM-ALK mediates phosphorylation of MSH2 at tyrosine 238, creating a functional deficiency in MSH2 and the loss of mismatch repair. Blood Cancer J 2015;5:e311. [PMID: 25978431 DOI: 10.1038/bcj.2015.35] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
10 Mjelle R, Hegre SA, Aas PA, Slupphaug G, Drabløs F, Saetrom P, Krokan HE. Cell cycle regulation of human DNA repair and chromatin remodeling genes. DNA Repair (Amst) 2015;30:53-67. [PMID: 25881042 DOI: 10.1016/j.dnarep.2015.03.007] [Cited by in Crossref: 140] [Cited by in F6Publishing: 144] [Article Influence: 17.5] [Reference Citation Analysis]
11 Nguyen TT, Hachisuga T, Urabe R, Kurita T, Kagami S, Kawagoe T, Shimajiri S, Nabeshima K. Significance of p53 expression in background endometrium in endometrial carcinoma. Virchows Arch 2015;466:695-702. [PMID: 25788166 DOI: 10.1007/s00428-015-1752-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
12 Tumiati M, Hemmes A, Uusivirta S, Koopal S, Kankainen M, Lehtonen E, Kuznetsov SG. Loss of Rad51c accelerates tumourigenesis in sebaceous glands of Trp53-mutant mice. J Pathol 2015;235:136-46. [PMID: 25270124 DOI: 10.1002/path.4455] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
13 Yan ZH, Cui LH, Wang XH, Li C, He X. Comparative study of mutations in SNP loci of K-RAS, hMLH1 and hMSH2 genes in neoplastic intestinal polyps and colorectal cancer. World J Gastroenterol 2014; 20(48): 18338-18345 [PMID: 25561800 DOI: 10.3748/wjg.v20.i48.18338] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
14 Liu L, Zhou W, Cheng CT, Ren X, Somlo G, Fong MY, Chin AR, Li H, Yu Y, Xu Y, O'Connor ST, O'Connor TR, Ann DK, Stark JM, Wang SE. TGFβ induces "BRCAness" and sensitivity to PARP inhibition in breast cancer by regulating DNA-repair genes. Mol Cancer Res 2014;12:1597-609. [PMID: 25103497 DOI: 10.1158/1541-7786.MCR-14-0201] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 4.6] [Reference Citation Analysis]
15 Xiao X, Melton DW, Gourley C. Mismatch repair deficiency in ovarian cancer — Molecular characteristics and clinical implications. Gynecologic Oncology 2014;132:506-12. [DOI: 10.1016/j.ygyno.2013.12.003] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 6.8] [Reference Citation Analysis]
16 de Oliveira DH, de Sousa Lopes ML, de Santana Sarmento DJ, Queiroz LM, da Costa Miguel MC, da Silveira EJ. Relationship between the epithelial expression of hMLH1, MDM2, and p63 and lower lip carcinogenesis. J Oral Pathol Med 2014;43:357-63. [PMID: 24329813 DOI: 10.1111/jop.12144] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
17 Jarzen J, Diamanduros A, Scarpinato KD. Mismatch repair proteins in recurrent prostate cancer. Adv Clin Chem 2013;60:65-84. [PMID: 23724741 DOI: 10.1016/b978-0-12-407681-5.00002-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
18 Kobayashi GS, Alvizi L, Sunaga DY, Francis-West P, Kuta A, Almada BV, Ferreira SG, de Andrade-Lima LC, Bueno DF, Raposo-Amaral CE, Menck CF, Passos-Bueno MR. Susceptibility to DNA damage as a molecular mechanism for non-syndromic cleft lip and palate. PLoS One 2013;8:e65677. [PMID: 23776525 DOI: 10.1371/journal.pone.0065677] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
19 Tomé S, Simard JP, Slean MM, Holt I, Morris GE, Wojciechowicz K, te Riele H, Pearson CE. Tissue-specific mismatch repair protein expression: MSH3 is higher than MSH6 in multiple mouse tissues. DNA Repair 2013;12:46-52. [DOI: 10.1016/j.dnarep.2012.10.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
20 Shen K, Ye Y, Jiang K, Liang B, Yang X, Wang S. MSH2 is required for cell proliferation, cell cycle control and cell invasiveness in colorectal cancer cells. Chin Sci Bull 2012;57:2580-2585. [DOI: 10.1007/s11434-012-5258-0] [Reference Citation Analysis]
21 Casey G. Genetics of Colon Cancer Susceptibility. Energy Balance and Gastrointestinal Cancer 2012. [DOI: 10.1007/978-1-4614-2367-6_2] [Reference Citation Analysis]
22 Ling ZQ, Li P, Ge MH, Hu FJ, Fang XH, Dong ZM, Mao WM. Aberrant methylation of different DNA repair genes demonstrates distinct prognostic value for esophageal cancer. Dig Dis Sci 2011;56:2992-3004. [PMID: 21674174 DOI: 10.1007/s10620-011-1774-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
23 Jensen LH, Kuramochi H, Crüger DG, Lindebjerg J, Kolvraa S, Danenberg P, Danenberg K, Jakobsen A. Gene expression of the mismatch repair gene MSH2 in primary colorectal cancer. Tumour Biol 2011;32:977-83. [PMID: 21732224 DOI: 10.1007/s13277-011-0199-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
24 Lee KH, Lee JS, Nam JH, Choi C, Lee MC, Park CS, Juhng SW, Lee JH. Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence. Langenbecks Arch Surg. 2011;396:1017-1026. [PMID: 21706233 DOI: 10.1007/s00423-011-0812-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
25 Souza LR, Fonseca-Silva T, Pereira CS, Santos EP, Lima LC, Carvalho HA, Gomez RS, Guimarães AL, De Paula AM. Immunohistochemical analysis of p53, APE1, hMSH2 and ERCC1 proteins in actinic cheilitis and lip squamous cell carcinoma. Histopathology 2011;58:352-60. [PMID: 21323960 DOI: 10.1111/j.1365-2559.2011.03756.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
26 Dore-Duffy P, Cleary K. Morphology and properties of pericytes. Methods Mol Biol 2011;686:49-68. [PMID: 21082366 DOI: 10.1007/978-1-60761-938-3_2] [Cited by in Crossref: 144] [Cited by in F6Publishing: 152] [Article Influence: 12.0] [Reference Citation Analysis]
27 Yu Y, Wang Y, Ren X, Tsuyada A, Li A, Liu LJ, Wang SE. Context-dependent bidirectional regulation of the MutS homolog 2 by transforming growth factor β contributes to chemoresistance in breast cancer cells. Mol Cancer Res 2010;8:1633-42. [PMID: 21047769 DOI: 10.1158/1541-7786.MCR-10-0362] [Cited by in Crossref: 67] [Cited by in F6Publishing: 71] [Article Influence: 5.2] [Reference Citation Analysis]
28 Sun W, Yang J. Functional mechanisms for human tumor suppressors. J Cancer 2010;1:136-40. [PMID: 20922055 DOI: 10.7150/jca.1.136] [Cited by in Crossref: 38] [Cited by in F6Publishing: 44] [Article Influence: 2.9] [Reference Citation Analysis]
29 Martin SA, McCarthy A, Barber LJ, Burgess DJ, Parry S, Lord CJ, Ashworth A. Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair gene MSH2. EMBO Mol Med 2009;1:323-37. [PMID: 20049736 DOI: 10.1002/emmm.200900040] [Cited by in Crossref: 127] [Cited by in F6Publishing: 135] [Article Influence: 9.8] [Reference Citation Analysis]
30 Zhao Y, Oki E, Ando K, Morita M, Kakeji Y, Maehara Y. The impact of a high-frequency microsatellite instability phenotype on the tumor location-related genetic differences in colorectal cancer. Cancer Genetics and Cytogenetics 2010;196:133-9. [DOI: 10.1016/j.cancergencyto.2009.09.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
31 Chapiro E, Leporrier N, Radford-weiss I, Bastard C, Mossafa H, Leroux D, Tigaud I, De Braekeleer M, Terré C, Brizard F, Callet-bauchu E, Struski S, Veronese L, Fert-ferrer S, Taviaux S, Lesty C, Davi F, Merle-béral H, Bernard OA, Sutton L, Raynaud SD, Nguyen-khac F. Gain of the short arm of chromosome 2 (2p) is a frequent recurring chromosome aberration in untreated chronic lymphocytic leukemia (CLL) at advanced stages. Leukemia Research 2010;34:63-8. [DOI: 10.1016/j.leukres.2009.03.042] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 3.5] [Reference Citation Analysis]
32 Lynch PM. The hMSH2 and hMLH1 genes in hereditary nonpolyposis colorectal cancer. Surg Oncol Clin N Am. 2009;18:611-624. [PMID: 19793569 DOI: 10.1016/j.soc.2009.08.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
33 Frazier AL, F. Amatruda J. Pediatric Germ Cell Tumors. Oncology of Infancy and Childhood 2009. [DOI: 10.1016/b978-1-4160-3431-5.00023-6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
34 Floer M, Binion DG, Nelson VM, Manley S, Wellner M, Sadeghi S, Behmaram B, Sewell C, Otterson MF, Kucharzik T, Rafiee P. Role of MutS homolog 2 (MSH2) in intestinal myofibroblast proliferation during Crohn's disease stricture formation. Am J Physiol Gastrointest Liver Physiol 2008;295:G581-90. [PMID: 18635600 DOI: 10.1152/ajpgi.90311.2008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
35 Courtay-cahen C, Platt SR, De Risio L, Starkey MP. Preliminary analysis of genomic abnormalities in canine meningiomas. Veterinary and Comparative Oncology 2008;6:182-92. [DOI: 10.1111/j.1476-5829.2008.00159.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
36 Chen H, He X, Wang Z, Wu D, Zhang H, Xu C, He H, Cui L, Ba D, He W. Identification of Human T Cell Receptor γδ-recognized Epitopes/Proteins via CDR3δ Peptide-based Immunobiochemical Strategy. Journal of Biological Chemistry 2008;283:12528-37. [DOI: 10.1074/jbc.m708067200] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 3.5] [Reference Citation Analysis]
37 Jänicke RU, Sohn D, Schulze-osthoff K. The dark side of a tumor suppressor: anti-apoptotic p53. Cell Death Differ 2008;15:959-76. [DOI: 10.1038/cdd.2008.33] [Cited by in Crossref: 147] [Cited by in F6Publishing: 149] [Article Influence: 9.8] [Reference Citation Analysis]
38 Young LC, Listgarten J, Trotter MJ, Andrew SE, Tron VA. Evidence that dysregulated DNA mismatch repair characterizes human nonmelanoma skin cancer. Br J Dermatol 2008;158:59-69. [PMID: 17970804 DOI: 10.1111/j.1365-2133.2007.08249.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
39 Seifert M, Scherer SJ, Edelmann W, Böhm M, Meineke V, Löbrich M, Tilgen W, Reichrath J. The DNA-mismatch repair enzyme hMSH2 modulates UV-B-induced cell cycle arrest and apoptosis in melanoma cells. J Invest Dermatol 2008;128:203-13. [PMID: 17611581 DOI: 10.1038/sj.jid.5700941] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]